[Durgical](https://durgical.com/en/) › [DurgiPedia](https://durgical.com/en/durgipedia/) › [Haematology](https://durgical.com/en/haematology/) › [White cells and leukaemia](https://durgical.com/en/haematology/areas/white-cells/) › Chronic leukaemias: CML versus CLL (and hairy cell leukaemia)

# Chronic leukaemias: CML versus CLL (and hairy cell leukaemia)

- Look-alikes compared

Chronic leukaemias are often found by chance on a routine blood test. CML and CLL share a name but behave and are treated very differently.

Updated Nov 19, 2026

## Key points

- CML: BCR::ABL1, t(9;22), basophils, huge [spleen](https://durgical.com/en/anatomy/spleen/), [tyrosine](https://durgical.com/en/biochemistry/molecules/tyrosine/) [kinase inhibitors](https://durgical.com/en/pharmacology/classes/kinase-inhibitors/).
- CLL: older adult, smudge cells, CD5+ CD23+ B cells, often watched.
- CLL complications: infections, AIHA, ITP, Richter transformation.
- Hairy cell: pancytopenia, big spleen, BRAF V600E, dry tap.
- Chronic = cells mature but too many.

On this page

- The basics Key points
- What it is
- How to think about it
- The difference in one line
- Chronic leukaemias and three rare look-alikes
- How it is confirmed
- Common traps
- Elsewhere in DurgiPedia

- Clinical In clinical practice

- Study Test yourself

- Connections Connections

## What it is

In the chronic leukaemias the malignant cells still mature, so the blood fills with cells that look nearly normal and the disease moves slowly. [Chronic myeloid leukaemia](https://durgical.com/en/conditions/chronic-myeloid-leukaemia/) (CML) is a myeloproliferative neoplasm driven by the BCR::ABL1 fusion (the Philadelphia chromosome, t(9;22)). [Chronic lymphocytic leukaemia](https://durgical.com/en/conditions/chronic-lymphocytic-leukaemia/) (CLL) is a lymphoma of mature B cells that circulates in the blood. Hairy cell leukaemia is a rarer mature B-cell leukaemia with pancytopenia and a big spleen.

## How to think about it

Chronic means the factory still finishes its products but makes far too many of one. CML overproduces a whole family of myeloid cells because one switch is jammed on; CLL slowly hoards long-lived, mature-looking B cells that do not die when they should, and with time crowd the nodes, the marrow and the immune system.

## The difference in one line

- CML: any adult age; a very high white count with neutrophils, myelocytes, basophils and eosinophils; a very large spleen; tyrosine kinase inhibitors aimed at BCR::ABL1 have made it a controllable disease for most patients.
- Untreated CML moves from a chronic phase to accelerated phase and blast crisis ([acute leukaemia](https://durgical.com/en/conditions/acute-leukaemia/)).
- CLL: older adults; a raised count of small mature lymphocytes with smudge cells; markers CD5, CD19, CD20 (weak) and CD23.
- CLL weakens immunity (low [antibodies](https://durgical.com/en/biochemistry/enzymes/immunoglobulins/)) and causes autoimmune haemolysis and ITP; it can transform into an aggressive lymphoma (Richter transformation).
- Early CLL without symptoms or cytopenias is watched, not treated: treatment starts when the disease causes problems.
- Hairy cell leukaemia: middle-aged men, pancytopenia, monocytopenia, big spleen without big nodes, BRAF V600E, a dry tap on marrow aspiration.
- LGL leukaemia: a slow clone of cytotoxic T cells (or NK cells), median age 55–60; neutropenia and infections dominate, about a third have an autoimmune disease (mostly [rheumatoid arthritis](https://durgical.com/en/conditions/rheumatoid-arthritis/)), and treatment, when needed, is immunosuppressive.
- Prolymphocytic leukaemia now means T-PLL: an aggressive mature T-cell leukaemia with a very high count, big [liver](https://durgical.com/en/anatomy/liver/) and spleen, and TCL1 and ATM changes. B-PLL was dropped from the 2022 WHO classification and its cases reassigned.
- BPDCN is not chronic: an aggressive blast neoplasm, mostly of older men, that usually starts in the skin and spreads to marrow, blood and nodes; its blasts are CD4+ CD56+ CD123+.

## Chronic leukaemias and three rare look-alikes

| Leukaemia | Line | Blood | Spleen and nodes | Marker | Main risks |
| --- | --- | --- | --- | --- | --- |
| [CML](https://durgical.com/en/conditions/chronic-myeloid-leukaemia/) | Myeloid | Very high white count, all stages of myeloid cells, basophils up | Very large spleen, nodes usually normal | BCR::ABL1, t(9;22) | Blast crisis if uncontrolled |
| [CLL](https://durgical.com/en/conditions/chronic-lymphocytic-leukaemia/) | Mature B lymphocytes | High count of small lymphocytes, smudge cells | Nodes enlarged, spleen variable | CD5 + CD23 on B cells (flow cytometry) | Infections, autoimmune cytopenias, Richter transformation |
| Hairy cell leukaemia | Mature B lymphocytes | Pancytopenia, few hairy cells, low monocytes | Very large spleen, nodes usually normal | BRAF V600E; CD11c, CD25, CD103 | Infections from pancytopenia |
| LGL leukaemia | Cytotoxic T cells (most) or NK cells | Excess large granular lymphocytes; neutropenia most often, also anaemia | Spleen enlarged in 20–50%, nodes rarely | Clonal T-cell receptor, CD3+ CD8+ CD57+; STAT3 mutation | Infections from neutropenia; rheumatoid arthritis, [pure red cell aplasia](https://durgical.com/en/conditions/pure-red-cell-aplasia/) |
| T-cell prolymphocytic leukaemia | Mature T cells | Very high count (often over 100 × 10⁹/L), anaemia, low platelets | Big liver and spleen, non-bulky nodes; skin, oedema or effusions in some | TCL1 overexpression, ATM loss | Aggressive: median survival under 3 years even with treatment |
| BPDCN | Plasmacytoid [dendritic cell](https://durgical.com/en/immunology/dendritic-cell/) precursors (blasts) | Blasts in the blood in 15–68%; marrow involved in 46–95% | Nodes involved in 24–63%, spleen in about 20% | CD4+ CD56+ CD123+, no T-cell marker (CD3 negative) | Skin lesions in 80–97%; rapidly fatal without intensive therapy |

## In clinical practice

- An older person with a lymphocytosis on a routine count and painless nodes most often has CLL.
- Left upper quadrant fullness or early satiety from a huge spleen is a common first complaint in CML.
- Patients with CLL need vaccinations and early treatment of infections because of low antibody levels.

## How it is confirmed

- Suspected CML: BCR::ABL1 by PCR (and cytogenetics or [FISH](https://durgical.com/en/histology/immunohistochemistry-and-in-situ-hybridization/)); the same PCR measures the response to treatment.
- Suspected CLL: flow cytometry of the blood confirms a clonal B-cell population with the typical markers; a marrow is not needed for diagnosis.
- CLL follow-up: count, immunoglobulins and DAT if anaemia appears; new rapidly growing nodes or B symptoms need a biopsy for Richter transformation.
- Pancytopenia with a big spleen and low monocytes: flow cytometry and marrow biopsy for hairy cell leukaemia.
- Suspected LGL leukaemia: blood flow cytometry (CD3, CD8, CD57, CD16, CD56) and T-cell receptor gene rearrangement for clonality.
- Skin nodules or plaques with blasts in an older man: skin biopsy stained for CD123, CD4 and CD56 to recognise BPDCN.

## Common traps

- **Treating early, symptom-free CLL**: watching is the standard because early treatment does not prolong life.
- **Confusing CML with a leukaemoid reaction**: basophilia, a big spleen and no cause point to CML; BCR::ABL1 decides.
- **Expecting high white counts in hairy cell leukaemia**: it usually presents with pancytopenia.
- **Forgetting autoimmune haemolysis in CLL**: it can be the cause of a falling haemoglobin.
- **Calling BPDCN a skin lymphoma or a chronic leukaemia**: it is an aggressive blast neoplasm that often starts in the skin and is recognised by CD123 on CD4+ CD56+ blasts.

## Test yourself

Think of the answer, then tap the question to see it.

## Why is CML called a myeloproliferative neoplasm while CLL is classed with the lymphomas?

CML is a stem-cell disease that overproduces myeloid cells through BCR::ABL1; CLL is a clone of mature B lymphocytes, the same cell family as small lymphocytic lymphoma.

## A 72-year-old has a high lymphocyte count, smudge cells and no symptoms. What confirms the diagnosis and what is usually done?

Flow cytometry showing clonal CD5+ CD23+ B cells confirms CLL; without symptoms or cytopenias the patient is usually monitored, not treated.

## A patient with CLL develops a falling haemoglobin and jaundice. What should you test for?

[Autoimmune haemolytic anaemia](https://durgical.com/en/conditions/autoimmune-haemolytic-anaemia/): DAT, reticulocytes, LDH, [bilirubin](https://durgical.com/en/biochemistry/molecules/bilirubin/) and haptoglobin.

## A 58-year-old with rheumatoid arthritis has repeated infections, severe neutropenia and many large granular lymphocytes. What is the likely diagnosis, and how is it confirmed?

T-cell LGL leukaemia; blood flow cytometry (CD3+ CD8+ CD57+) and a clonal T-cell receptor rearrangement confirm it, and a STAT3 mutation supports it.

[Add to my cards (4)](https://durgical.app/estudiar/?add=/en/haematology/chronic-leukaemias-cml-versus-cll/)

## Elsewhere in DurgiPedia

- [Chronic myeloid leukaemia](https://durgical.com/en/general-pathology/chronic-myeloid-leukaemia/)
- [Chronic lymphocytic leukaemia (CLL/SLL)](https://durgical.com/en/general-pathology/chronic-lymphocytic-leukaemia/)
- [Hairy cell leukaemia: BRAF V600E, the dry tap and the red-pulp spleen](https://durgical.com/en/general-pathology/hairy-cell-leukaemia-braf-v600e-the-dry-tap-and-the-red-pulp-spleen/)
- [Clonality testing: telling lymphoma from a reactive response](https://durgical.com/en/immunology/clonality-testing-telling-lymphoma-from-a-reactive-response/)
- [T- and NK-cell leukaemias and extranodal lymphomas](https://durgical.com/en/general-pathology/t-and-nk-cell-leukaemias-and-extranodal-lymphomas/)

## Connections

## Related 5

- [A high or low white count: which cell, and is it mature?](https://durgical.com/en/haematology/a-high-or-low-white-count-which-cell-and-is-it-mature/)
- [Acute leukaemias: AML, ALL and the emergency called APL](https://durgical.com/en/haematology/acute-leukaemias-aml-all-and-the-emergency-called-apl/)
- [Myeloproliferative neoplasms and myelodysplasia: too much or made badly](https://durgical.com/en/haematology/myeloproliferative-neoplasms-and-myelodysplasia-too-much-or-made-badly/)
- [Hodgkin versus non-Hodgkin lymphoma](https://durgical.com/en/haematology/hodgkin-versus-non-hodgkin-lymphoma/)
- [CML on tyrosine kinase inhibitors: response milestones and resistance](https://durgical.com/en/haematology/cml-on-tyrosine-kinase-inhibitors-response-milestones-and-resistance/)

## Related conditions 3

- [Chronic myeloid leukaemia](https://durgical.com/en/conditions/chronic-myeloid-leukaemia/)
- [Chronic lymphocytic leukaemia](https://durgical.com/en/conditions/chronic-lymphocytic-leukaemia/)
- [Autoimmune haemolytic anaemia](https://durgical.com/en/conditions/autoimmune-haemolytic-anaemia/)

## In Pharmacology 1

- [Imatinib](https://durgical.com/en/pharmacology/imatinib/)

[← All of haematology](https://durgical.com/en/haematology/)

Educational content; it does not replace assessment by a doctor or your institution's protocols. It contains no doses.

Sources: [Chronic myelogenous leukemia (CML)](https://medlineplus.gov/ency/article/000570.htm) (MedlinePlus, US National Library of Medicine, 2024); [Chronic lymphocytic leukemia (CLL)](https://medlineplus.gov/ency/article/000532.htm) (MedlinePlus, US National Library of Medicine, 2024); [Chronic Lymphocytic Leukemia Treatment (PDQ®)–Patient Version](https://www.cancer.gov/types/leukemia/patient/cll-treatment-pdq) (National Cancer Institute (NCI), 2026); [Hairy Cell Leukemia Treatment (PDQ®)–Patient Version](https://www.cancer.gov/types/leukemia/patient/hairy-cell-treatment-pdq) (National Cancer Institute (NCI), 2026); [Large Granular Lymphocytic Leukemia: Clinical Features, Molecular Pathogenesis, Diagnosis and Treatment](https://europepmc.org/article/PMC/PMC11011145) (Cancers (Europe PMC), 2024); [T-Cell Prolymphocytic Leukemia: Diagnosis, Pathogenesis, and Treatment](https://europepmc.org/article/PMC/PMC10419310) (International Journal of Molecular Sciences (Europe PMC), 2023); [Obituary for a diagnosis: B-cell prolymphocytic leukaemia (1974–2022)](https://europepmc.org/article/PMC/PMC10878189) (HemaSphere (Europe PMC), 2024); [Diagnostic approach to blastic plasmacytoid dendritic cell neoplasm: historical perspectives and current understanding](https://europepmc.org/article/PMC/PMC12051425) (Journal of Clinical and Experimental Hematopathology (Europe PMC), 2025).

## **Spotted a mistake?** We are always improving for the community. Tell us what is wrong and our team will review it. Report a mistake

Representative model, for educational purposes only.

---
Source: https://durgical.com/en/haematology/chronic-leukaemias-cml-versus-cll/
License: CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). Cite as: DurgiPedia (durgical.com), https://durgical.com/en/haematology/chronic-leukaemias-cml-versus-cll/
